TrialBritish journal of cancer2008

Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients.

E Rouits et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.